nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—Cisplatin—peripheral nervous system neoplasm	0.363	1	CbGbCtD
Cysteamine—SST—vagus nerve—peripheral nervous system neoplasm	0.05	0.336	CbGeAlD
Cysteamine—SST—cranial nerve—peripheral nervous system neoplasm	0.0381	0.256	CbGeAlD
Cysteamine—SST—nerve—peripheral nervous system neoplasm	0.0195	0.131	CbGeAlD
Cysteamine—SST—ganglion—peripheral nervous system neoplasm	0.0193	0.13	CbGeAlD
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—NF1—peripheral nervous system neoplasm	0.0114	0.0892	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.0111	0.0873	CbGpPWpGaD
Cysteamine—SST—trigeminal ganglion—peripheral nervous system neoplasm	0.00946	0.0636	CbGeAlD
Cysteamine—SST—brainstem—peripheral nervous system neoplasm	0.00837	0.0563	CbGeAlD
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—BDNF—peripheral nervous system neoplasm	0.00614	0.0481	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00521	0.0408	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.005	0.0392	CbGpPWpGaD
Cysteamine—SST—cerebellum—peripheral nervous system neoplasm	0.00413	0.0278	CbGeAlD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.0035	0.0274	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00335	0.0263	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00321	0.0251	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00294	0.023	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.0029	0.0227	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00266	0.0209	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00255	0.02	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00255	0.02	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00245	0.0192	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00239	0.0188	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00234	0.0184	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.0023	0.018	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00225	0.0176	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00205	0.016	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00198	0.0155	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00189	0.0148	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00173	0.0135	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00166	0.013	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00157	0.0123	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00151	0.0118	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.0015	0.0118	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00144	0.0113	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00137	0.0107	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00131	0.0103	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00131	0.0103	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00126	0.00984	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.0012	0.00938	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.0012	0.00937	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00115	0.00899	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00114	0.00894	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00109	0.00857	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00105	0.0082	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00104	0.00811	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.001	0.00786	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000993	0.00778	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000956	0.00749	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000916	0.00718	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.0009	0.00705	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000807	0.00633	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000774	0.00606	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000774	0.00606	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000742	0.00581	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000676	0.0053	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000655	0.00513	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000648	0.00508	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000614	0.00481	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000612	0.00479	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.00061	0.00478	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000607	0.00476	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.0006	0.0047	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000591	0.00463	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000589	0.00461	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000587	0.0046	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000567	0.00444	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000565	0.00442	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000541	0.00424	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000537	0.00421	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000515	0.00403	CbGpPWpGaD
Cysteamine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000495	0.00137	CcSEcCtD
Cysteamine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000494	0.00137	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.000492	0.00136	CcSEcCtD
Cysteamine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000492	0.00136	CcSEcCtD
Cysteamine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00049	0.00136	CcSEcCtD
Cysteamine—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00136	CcSEcCtD
Cysteamine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000485	0.00134	CcSEcCtD
Cysteamine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.00133	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000479	0.00375	CbGpPWpGaD
Cysteamine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000477	0.00132	CcSEcCtD
Cysteamine—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000474	0.00131	CcSEcCtD
Cysteamine—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.00131	CcSEcCtD
Cysteamine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000471	0.00131	CcSEcCtD
Cysteamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000471	0.00131	CcSEcCtD
Cysteamine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00047	0.0013	CcSEcCtD
Cysteamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000467	0.00129	CcSEcCtD
Cysteamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000467	0.00129	CcSEcCtD
Cysteamine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000467	0.00129	CcSEcCtD
Cysteamine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000464	0.00129	CcSEcCtD
Cysteamine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000463	0.00128	CcSEcCtD
Cysteamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000461	0.00128	CcSEcCtD
Cysteamine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000459	0.00127	CcSEcCtD
Cysteamine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000458	0.00127	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.00126	CcSEcCtD
Cysteamine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000455	0.00126	CcSEcCtD
Cysteamine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000455	0.00126	CcSEcCtD
Cysteamine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000454	0.00126	CcSEcCtD
Cysteamine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00126	CcSEcCtD
Cysteamine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000451	0.00125	CcSEcCtD
Cysteamine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000449	0.00124	CcSEcCtD
Cysteamine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000449	0.00124	CcSEcCtD
Cysteamine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000447	0.00124	CcSEcCtD
Cysteamine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000442	0.00122	CcSEcCtD
Cysteamine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.00122	CcSEcCtD
Cysteamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000437	0.00121	CcSEcCtD
Cysteamine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000437	0.00121	CcSEcCtD
Cysteamine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000435	0.0012	CcSEcCtD
Cysteamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000434	0.0012	CcSEcCtD
Cysteamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000434	0.0012	CcSEcCtD
Cysteamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000428	0.00119	CcSEcCtD
Cysteamine—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000428	0.00119	CcSEcCtD
Cysteamine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000427	0.00118	CcSEcCtD
Cysteamine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000427	0.00118	CcSEcCtD
Cysteamine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000425	0.00118	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000424	0.00118	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000424	0.00332	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000424	0.00117	CcSEcCtD
Cysteamine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000423	0.00117	CcSEcCtD
Cysteamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000423	0.00117	CcSEcCtD
Cysteamine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000422	0.00117	CcSEcCtD
Cysteamine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000421	0.00117	CcSEcCtD
Cysteamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000419	0.00116	CcSEcCtD
Cysteamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000419	0.00116	CcSEcCtD
Cysteamine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000418	0.00116	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00115	CcSEcCtD
Cysteamine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.00115	CcSEcCtD
Cysteamine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000412	0.00114	CcSEcCtD
Cysteamine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.00114	CcSEcCtD
Cysteamine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00041	0.00114	CcSEcCtD
Cysteamine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00041	0.00114	CcSEcCtD
Cysteamine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00113	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000407	0.00319	CbGpPWpGaD
Cysteamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000407	0.00113	CcSEcCtD
Cysteamine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000405	0.00112	CcSEcCtD
Cysteamine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.00112	CcSEcCtD
Cysteamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000403	0.00112	CcSEcCtD
Cysteamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000403	0.00112	CcSEcCtD
Cysteamine—Rash—Topotecan—peripheral nervous system neoplasm	0.000403	0.00112	CcSEcCtD
Cysteamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000403	0.00112	CcSEcCtD
Cysteamine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000403	0.00112	CcSEcCtD
Cysteamine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000402	0.00112	CcSEcCtD
Cysteamine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000402	0.00111	CcSEcCtD
Cysteamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000401	0.00111	CcSEcCtD
Cysteamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0004	0.00111	CcSEcCtD
Cysteamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.0004	0.00111	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.0004	0.00111	CcSEcCtD
Cysteamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0004	0.00111	CcSEcCtD
Cysteamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0004	0.00111	CcSEcCtD
Cysteamine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000399	0.00111	CcSEcCtD
Cysteamine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000398	0.0011	CcSEcCtD
Cysteamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000398	0.0011	CcSEcCtD
Cysteamine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000398	0.0011	CcSEcCtD
Cysteamine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000398	0.0011	CcSEcCtD
Cysteamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000397	0.0011	CcSEcCtD
Cysteamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000397	0.0011	CcSEcCtD
Cysteamine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000397	0.0011	CcSEcCtD
Cysteamine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.0011	CcSEcCtD
Cysteamine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000396	0.0011	CcSEcCtD
Cysteamine—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.0011	CcSEcCtD
Cysteamine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000395	0.00109	CcSEcCtD
Cysteamine—Rash—Melphalan—peripheral nervous system neoplasm	0.000395	0.00109	CcSEcCtD
Cysteamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000394	0.00109	CcSEcCtD
Cysteamine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000393	0.00109	CcSEcCtD
Cysteamine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00039	0.00108	CcSEcCtD
Cysteamine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00108	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000389	0.00108	CcSEcCtD
Cysteamine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000387	0.00107	CcSEcCtD
Cysteamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000382	0.00106	CcSEcCtD
Cysteamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000382	0.00106	CcSEcCtD
Cysteamine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00038	0.00105	CcSEcCtD
Cysteamine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00038	0.00105	CcSEcCtD
Cysteamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00038	0.00105	CcSEcCtD
Cysteamine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000379	0.00105	CcSEcCtD
Cysteamine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000378	0.00105	CcSEcCtD
Cysteamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000377	0.00104	CcSEcCtD
Cysteamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000377	0.00104	CcSEcCtD
Cysteamine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000375	0.00104	CcSEcCtD
Cysteamine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.00104	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000373	0.00292	CbGpPWpGaD
Cysteamine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.00103	CcSEcCtD
Cysteamine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000372	0.00103	CcSEcCtD
Cysteamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000372	0.00103	CcSEcCtD
Cysteamine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.00102	CcSEcCtD
Cysteamine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000366	0.00101	CcSEcCtD
Cysteamine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000366	0.00101	CcSEcCtD
Cysteamine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.00101	CcSEcCtD
Cysteamine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000364	0.00101	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000363	0.00284	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000358	0.0028	CbGpPWpGaD
Cysteamine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000358	0.000991	CcSEcCtD
Cysteamine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000356	0.000987	CcSEcCtD
Cysteamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000355	0.000983	CcSEcCtD
Cysteamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.000981	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000354	0.00098	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000348	0.00272	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000346	0.00271	CbGpPWpGaD
Cysteamine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000345	0.000956	CcSEcCtD
Cysteamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000341	0.000946	CcSEcCtD
Cysteamine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000338	0.000935	CcSEcCtD
Cysteamine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000334	0.000924	CcSEcCtD
Cysteamine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000332	0.000921	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000331	0.0026	CbGpPWpGaD
Cysteamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00033	0.000913	CcSEcCtD
Cysteamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.000911	CcSEcCtD
Cysteamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000327	0.000906	CcSEcCtD
Cysteamine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000326	0.000904	CcSEcCtD
Cysteamine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000898	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000324	0.000898	CcSEcCtD
Cysteamine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000324	0.000897	CcSEcCtD
Cysteamine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000323	0.000896	CcSEcCtD
Cysteamine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000321	0.000889	CcSEcCtD
Cysteamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.000881	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000317	0.00249	CbGpPWpGaD
Cysteamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000317	0.000878	CcSEcCtD
Cysteamine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000309	0.000857	CcSEcCtD
Cysteamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000308	0.000853	CcSEcCtD
Cysteamine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000307	0.00085	CcSEcCtD
Cysteamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000306	0.000849	CcSEcCtD
Cysteamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.000847	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000304	0.00238	CbGpPWpGaD
Cysteamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.00084	CcSEcCtD
Cysteamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.000839	CcSEcCtD
Cysteamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000302	0.000836	CcSEcCtD
Cysteamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.000834	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000831	CcSEcCtD
Cysteamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000298	0.000826	CcSEcCtD
Cysteamine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000297	0.000822	CcSEcCtD
Cysteamine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000297	0.000822	CcSEcCtD
Cysteamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000294	0.000816	CcSEcCtD
Cysteamine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000294	0.000814	CcSEcCtD
Cysteamine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00081	CcSEcCtD
Cysteamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000292	0.000809	CcSEcCtD
Cysteamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000292	0.000809	CcSEcCtD
Cysteamine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000806	CcSEcCtD
Cysteamine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000804	CcSEcCtD
Cysteamine—Headache—Vincristine—peripheral nervous system neoplasm	0.00029	0.000804	CcSEcCtD
Cysteamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000286	0.000791	CcSEcCtD
Cysteamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00028	0.000777	CcSEcCtD
Cysteamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000276	0.000766	CcSEcCtD
Cysteamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000275	0.000762	CcSEcCtD
Cysteamine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00075	CcSEcCtD
Cysteamine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000269	0.000746	CcSEcCtD
Cysteamine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000746	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000744	CcSEcCtD
Cysteamine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000741	CcSEcCtD
Cysteamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00026	0.000722	CcSEcCtD
Cysteamine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000719	CcSEcCtD
Cysteamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000258	0.000716	CcSEcCtD
Cysteamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000258	0.000715	CcSEcCtD
Cysteamine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000714	CcSEcCtD
Cysteamine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000714	CcSEcCtD
Cysteamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000257	0.000711	CcSEcCtD
Cysteamine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000701	CcSEcCtD
Cysteamine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000694	CcSEcCtD
Cysteamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000248	0.000688	CcSEcCtD
Cysteamine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000686	CcSEcCtD
Cysteamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000243	0.000674	CcSEcCtD
Cysteamine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000665	CcSEcCtD
Cysteamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000239	0.000661	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000661	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000661	CcSEcCtD
Cysteamine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000238	0.00066	CcSEcCtD
Cysteamine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000656	CcSEcCtD
Cysteamine—Rash—Etoposide—peripheral nervous system neoplasm	0.000237	0.000656	CcSEcCtD
Cysteamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000236	0.000655	CcSEcCtD
Cysteamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000235	0.000651	CcSEcCtD
Cysteamine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000648	CcSEcCtD
Cysteamine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000642	CcSEcCtD
Cysteamine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000639	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000224	0.00176	CbGpPWpGaD
Cysteamine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000619	CcSEcCtD
Cysteamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000223	0.000618	CcSEcCtD
Cysteamine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000617	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00022	0.00173	CbGpPWpGaD
Cysteamine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000611	CcSEcCtD
Cysteamine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000607	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000604	CcSEcCtD
Cysteamine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000601	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000215	0.00169	CbGpPWpGaD
Cysteamine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000591	CcSEcCtD
Cysteamine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000588	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000211	0.00166	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000583	CcSEcCtD
Cysteamine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000573	CcSEcCtD
Cysteamine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000572	CcSEcCtD
Cysteamine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00057	CcSEcCtD
Cysteamine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000566	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000559	CcSEcCtD
Cysteamine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000556	CcSEcCtD
Cysteamine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000556	CcSEcCtD
Cysteamine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000544	CcSEcCtD
Cysteamine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000539	CcSEcCtD
Cysteamine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000529	CcSEcCtD
Cysteamine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000524	CcSEcCtD
Cysteamine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000518	CcSEcCtD
Cysteamine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000514	CcSEcCtD
Cysteamine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000513	CcSEcCtD
Cysteamine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000507	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000503	CcSEcCtD
Cysteamine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000502	CcSEcCtD
Cysteamine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000498	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000174	0.00137	CbGpPWpGaD
Cysteamine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00048	CcSEcCtD
Cysteamine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000479	CcSEcCtD
Cysteamine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000477	CcSEcCtD
Cysteamine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000475	CcSEcCtD
Cysteamine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000469	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000466	CcSEcCtD
Cysteamine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000465	CcSEcCtD
Cysteamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000463	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000167	0.00131	CbGpPWpGaD
Cysteamine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000461	CcSEcCtD
Cysteamine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000461	CcSEcCtD
Cysteamine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000461	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000164	0.00129	CbGpPWpGaD
Cysteamine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000444	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00016	0.00125	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000441	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000158	0.00124	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000157	0.00123	CbGpPWpGaD
Cysteamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000429	CcSEcCtD
Cysteamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000428	CcSEcCtD
Cysteamine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000426	CcSEcCtD
Cysteamine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000426	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000153	0.0012	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000152	0.00119	CbGpPWpGaD
Cysteamine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000418	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000145	0.00114	CbGpPWpGaD
Cysteamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000399	CcSEcCtD
Cysteamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000397	CcSEcCtD
Cysteamine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000387	CcSEcCtD
Cysteamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000385	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000139	0.00109	CbGpPWpGaD
Cysteamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000371	CcSEcCtD
Cysteamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000369	CcSEcCtD
Cysteamine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000367	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000133	0.00104	CbGpPWpGaD
Cysteamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000367	CcSEcCtD
Cysteamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000365	CcSEcCtD
Cysteamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000357	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000127	0.000996	CbGpPWpGaD
Cysteamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000346	CcSEcCtD
Cysteamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000343	CcSEcCtD
Cysteamine—SST—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000123	0.000967	CbGpPWpGaD
Cysteamine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00034	CcSEcCtD
Cysteamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00034	CcSEcCtD
Cysteamine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000338	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000118	0.000927	CbGpPWpGaD
Cysteamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.00032	CcSEcCtD
Cysteamine—SST—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000101	0.000794	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.72e-05	0.000762	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.7e-05	0.00076	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.3e-05	0.000728	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.56e-05	0.000671	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.21e-05	0.000643	CbGpPWpGaD
